2017
T-DM1 — an important agent in the history of breast cancer management
Metzger-Filho O, Winer EP. T-DM1 — an important agent in the history of breast cancer management. Nature Reviews Clinical Oncology 2017, 14: 651-652. PMID: 28786416, DOI: 10.1038/nrclinonc.2017.123.Peer-Reviewed Original ResearchConceptsT-DM1HER2-positive breast cancerOverall survival benefitFavorable safety profileBreast cancer managementRelevant therapeutic targetTH3RESA trialProlonged followSurvival benefitSafety profileBreast cancerCancer managementTherapeutic targetLater linesImportant agentsPatientsHER2FollowCancerDiseaseTrials
2005
Standards for follow-up care of patients with breast cancer
Peppercorn J, Partridge A, Burstein HJ, Winer EP. Standards for follow-up care of patients with breast cancer. The Breast 2005, 14: 500-508. PMID: 16288876, DOI: 10.1016/j.breast.2005.09.001.Peer-Reviewed Original ResearchConceptsBreast cancer survivorsCancer survivorsBreast cancerEarly identificationNew primary cancerInvasive breast cancerCare of patientsCost-effective followLocoregional recurrenceLate complicationsDistant metastasisPrimary cancerRandomized trialsDuctal carcinomaComprehensive carePET scansSuch carePsychosocial problemsCareCancerSurvivorsRecurrenceFollowMore yearsBreast diagnosis